Calendar GENFIT Xetra

Stocks

XUP

FR0004163111

Biotechnology & Medical Research

Market Closed - Xetra 10:08:41 2026-10-02 EDT			5-day change	1st Jan Change
9.040 ^EUR	-5.24%		-14.07%	+69.77%

09-28	Genfit S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-15	French and Benelux stocks-Factors to watch on September 15	RE

Chart calendar GENFIT

a07b3bf64f27dfc1c5426fb776.GfhWZW61nlZDyxJEaIBcwn0EwGL1YwHUdVFdlXDn9Z8.QcEeI1aH_xp3pWsOANk9qTg38Qy4OWOXOCUa8CWSgPVNjTcxW5j1ADu_Ww~8d0e96e64032fe91d0592f9c77c4c753

Upcoming events on GENFIT

2026-11-04

Sales and Revenue Release - Q3 2026

Past events on GENFIT

2026-09-29	Earnings release - Q2 2026
2026-09-09	Information meeting	10:00
2026-06-15	Présentation aux Actionnaires / Analystes	04:00
2026-06-14	Extraordinary General Meeting
2026-06-14	Annual General Meeting
2026-05-20	Sales and Revenue Release - Q1 2026
2026-04-02	Earnings release - Annual 2025
2026-02-25	Sales and Revenue Release - Annual 2025
2025-11-19	Sales and Revenue Release - Q3 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million EUR	Released Forecast Spread	38,2 61,6 -38.07%	70,9 77,4 -8.31%	71,1 66,8 6.43%	93,8	130	168
EBITDA Million EUR	Released Forecast Spread	-24,9 -38,2 34.76%	5,01 29,4 -82.98%	-51,8 -41,3 -25.29%	28,2	62,9	80,9
EBIT Million EUR	Released Forecast Spread	-26,6 -25,4 -4.81%	3,28 16,8 -80.47%	-4,50 -5,35 15.87%	34,3	70,7	91,0
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-28,5 5,23 -645.39%	1,85 2,70 -31.59%	-86,5 -5,35 -1515.44%	42,7	126	122
Net income Million EUR	Released Forecast Spread	-28,9 -21,9 -32.17%	1,51 20,1 -92.51%	-86,0 -8,30 -935.48%	18,4	10,4	53,2
EPS EUR	Released Forecast Spread	-0,58 -0,56 -3.66%	0,03 0,26 -88.24%	-1,72 -0,10 -1656.36%	0,26	0,09	1,07
Announcement Date		04/04/24	24/04/25	02/04/26	-

Quarterly results

Fiscal Period	June	2024 S1	2024 Q4	2024 S2	2025 Q1	2025 S1	2025 S2	2026 Q1	2026 S1	2026 S2
Net sales Million EUR	Released Forecast Spread	61,2 48,3 26.79%	11,2 7,30 53.96%	9,74 23,1 -57.77%	2,80 133 -97.89%	35,7 98,6 -63.81%	35,4 42,1 -15.81%	9,60 9,50 1.05%	30,5	37,2
EBIT Million EUR	Released Forecast Spread	31,2 21,1 48.11%		-27,9 -26,8 -4.26%		0,08 57,9 -99.87%	-4,50 4,40 -202.29%
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	30,3 22,8 32.93%		-28,5 -27,6 -3.27%		-10,1 57,8 -117.49%	-76,4 3,30 -2415.06%
Net income Million EUR	Released Forecast Spread	30,3 17,2 76.02%		-28,8 -11,5 -150.47%		-9,96 51,4 -119.37%	-76,0 0,85 -9042.59%		-8,00	-5,20
EPS EUR	Released Forecast Spread	0,53 0,49 8.16%		-0,50 -0,55 9.09%		-0,20 2,18 -109.17%			-0,16	-0,10
Announcement Date		19/09/24	24/04/25	24/04/25	22/05/25	22/09/25	02/04/26	21/05/26	-	-

Upcoming sector events for GENFIT

2026-10-06	BASILEA PHARMACEUTICA AG	Information meeting
2026-10-06	OMNIAB, INC.	Analyst/Investor Day	11:00
2026-10-12	LONZA GROUP AG	Analyst/Investor Day
2026-10-12	BIDE PHARMATECH CO., LTD.	Extraordinary General Meeting	22:00
2026-10-13	GEMPHARMATECH CO., LTD.	Earnings presentation	22:00
2026-10-14	LONZA GROUP AG	Analyst/Investor Day	12:00
2026-10-18	GEMPHARMATECH CO., LTD.	Extraordinary General Meeting	22:00
2026-10-20	ARCUS BIOSCIENCES, INC.	Information meeting	08:30
2026-10-20	4D MOLECULAR THERAPEUTICS, INC.	Analyst/Investor Day
2026-10-21	MEDPACE HOLDINGS, INC.	Earnings release - Q3 2026

Past sector events for GENFIT

2026-10-01	MONTE ROSA THERAPEUTICS, INC.	Information meeting	08:00
2026-09-30	JADE BIOSCIENCES, INC.	Information meeting	08:30
2026-09-29	ADLAI NORTYE GROUP LTD.	Extraordinary General Meeting	22:00
2026-09-28	SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.	Extraordinary General Meeting	02:30
2026-09-28	R&G PHARMASTUDIES CO., LTD.	Extraordinary General Meeting	02:30
2026-09-24	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Analyst/Investor Day	09:00
2026-09-24	ACADIA PHARMACEUTICALS INC.	Information meeting	08:00
2026-09-23	BIO-TECHNE CORPORATION	Extraordinary General Meeting	09:00
2026-09-23	BIO-TECHNE CORPORATION	Présentation aux Actionnaires / Analystes	09:00
2026-09-23	HANGZHOU TIGERMED CONSULTING CO., LTD	Extraordinary General Meeting	03:00

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

The best tools reserved for subscribers to boost the performance of your investments!